CorMedix Inc.
Develops a catheter lock solution to prevent bloodstream infections in hemodialysis patients.
CRMD | NDAQ
Overview
Corporate Details
- ISIN(s):
- US21900C3088
- LEI:
- Country:
- United States of America
- Address:
- 300 CONNELL DRIVE, 7922 BERKELEY HEIGHTS
- Website:
- https://cormedix.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, particularly infectious diseases. The company's lead product is DefenCath® (taurolidine and heparin), a proprietary antibacterial and antifungal catheter lock solution. DefenCath is designed to reduce the incidence of catheter-related bloodstream infections (CRBSIs) in patients with kidney failure receiving chronic hemodialysis through a central venous catheter. The company's primary commercial efforts are directed towards addressing this critical unmet medical need in the hemodialysis patient population.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CorMedix Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CorMedix Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CorMedix Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
